GW26-e3972 Non-alcoholic fatty liver disease affects the relationship between epicardium and coronary atherosclerotic heart disease  by Cai, He et al.
C136 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5logistic regression analysis was used to evaluate the predictive values
of serum BMPs.
RESULTS Subjects with Agatston score  400 (n¼254) had higher
serum levels of BMP-2 (116.3 12.5pg/ml vs. 87.8 10.7pg/ml,
p<0.001), BMP-4 (91.2 9.7pg/ml vs. 73.28.7pg/ml, p¼0.017) and
BMP-7 (91.2 8.3pg/ml vs. 51.3 5.9pg/ml, p<0.001) than those
with Agatston score < 400 (n¼319). Agatston scores were posi-
tively correlated with the serum levels of BMP-2 (r¼0.624, p<0.001),
BMP-4 (r¼0.503, p<0.001) and BMP-7(r¼0.662, p<0.001). After
adjustment for other risk factors, multivariate logistic regres-
sion analysis considered that increased serum levels of BMP-2
[OR:1.646(1.125,3.073), p<0.001], BMP-4 [OR:1.243(1.033,3.135),
p¼0.023] and BMP-7 [OR:2.085(1.376,3.598), p<0.001] were indepen-
dent predictors for the progression of CAC.
CONCLUSIONS Serum BMP-2, BMP-4 and BMP-7 can predict the CAC
in the elderly.
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Pridictive Value of Soluble Urokinase-type Plasminogen Activator
Receptor in Patients with Acute Coronary Syndrome Undergoing
Percutaneous Coronary Intervention
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Lin Chen, Xiaoxian Qian
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510630, China
OBJECTIVES To uncover the value of Soluble urokinase-type plas-
minogen activator receptor (su-PAR) in predicting major adverse
cardiovascular events (MACE) among patients with acute coronary
syndrome (ACS) undergoing percutaneous coronary intervention
(PCI).
METHODS A total of 103 patients with ACS undergoing PCI in Cardi-
ology Department of SUN Yat-sen University The Third Afﬁliated
Hospital between June 2005 to August 2006 were enrolled. In all these
patients, we measured the lever of su-PAR in plasma with a solid
phaseenzyme-linked immuneosorbent assay (ELISA) when the cases
were brought into this study and two weeks after they were brought
into this study. We divided all the cases into three groups according to
the u-PAR. The end points were all-cause mortality and fatal or
nonfatal recurrent myocardial infarction (MI).
RESULTS During a median follow-up period of 7 years, 13 deaths and 3
fatal and 11 nonfatal recurrent MIs occurred. MACE rates of low, in-
termediate, and high tertiles according to the su-PAR were 12.1%,
20.0% and 31.4%, respectively. Both univariate analysis and multi-
variate analysis showed that the su-PAR was the independent pre-
dictor of MACE (HR¼2.28, 95%CI (1.41, 3.39), P¼0.002; HR¼2.16, 95%
CI (1.32, 3.38), P¼0.005).
CONCLUSIONS Urokinase-type plasminogen activator receptor could
be a independent risk predictor of major adverse cardiovascular
events among patients with acute coronary syndrome undergoing
percutaneous coronary intervention.
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The Relation between Glycosylated Hemoglobin and Severity of Coronary
Artery Lesions in Patients with Coronary Heart Disease and Type 2
Diabetes Mellitus
Jianrui Zheng, Zhenda Zheng, Xing Shui, Dinghui Liu,
Zheqi Wen, Chen Lin
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OBJECTIVES To ﬁnd the relationship between different levels of
glycosylated hemoglobin and severity of coronary artery lesions in
patients with coronary heart disease and type 2 diabetes mellitus.
METHODS We collected the data of 184 patients with coronary heart
disease and type 2 diabetes mellitus. Then the patients were divided
into three groups based on glycosylated hemoglobin levels including
group A (n¼70, HbA1C7.0%), group B (n¼37, 7.0%<HbA1C<8.0%),
and group C (n¼77, HbA1C8.0%). Gensini score was used to assess
the severity of coronary lesions by coronary angiography. All statis-
tical tests were operated with program SPSS13.0 and P<0.05 was
considered statistically signiﬁcant.
RESULTS (1) The incidence of left main lesions was 7.1%, 2.7%, and
10.4% in group A, group B, group C, respectively. The prevalence of
diffuse lesions in each group was 32.9%, 24.3%, and 26.0%, respec-
tively. The prevalence of complete occlusive lesions in each groupwas 28.6%, 27.0%, and 27.3%, respectively. There were no sig-
niﬁcant differences in the left main lesions, diffuse lesions, and
complete occlusive lesions between three groups (P>0.05). (2) The
median of Gensini score of threegroups was 57.75, 56.00, 46.00,
respectively. By square root transformation, all the ratios of the
Gensini score are normal distribution, One-way ANOVA was used as
appropriate to compare means among different groups, and the re-
sults show no signiﬁcant differences between the three groups
(P>0.05).
CONCLUSIONS Among patients with coronary heart disease and type
2 diabetes mellitus, there was no signiﬁcant correlation between
glycosylated hemoglobin and severity of coronary artery lesions.
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Correlation between clopidogrel low response and CYP2C19 gene
polymorphism in CAD patients after PCI
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OBJECTIVES To explore the correlation between clopidogrel low
response and CYP2C19 gene polymorphism in coronary artery disease
(CAD) patients after percutaneous coronary intervention (PCI ).
METHODS A total of 200 patients with CAD after PCI are admitted to
our hospital from October 2013 to October 2014 in this study, and
treated with dual antiplatelet drugs, aspirin and clopidogrel. The
clopidogrel response is judged by depending on the ADP-induced
platelet inhibition rate tested by thromboelastogram. In this study the
ADP-induced platelet inhibition rate less than 30% is deﬁned as clo-
pidogrel low response and the gene chip detection technology is used
to detect the genotype of CYP2C19 to further explore the correlation
between clopidogrel low response and CYP2C19 gene polymorphism
in CAD patients after PCI.
RESULTS In these 200 patients, the ADP-induced platelet inhibition
rate is signiﬁcantly statistical difference between patients carrying
CYP2C19*1/*1 and CYP2C19*1/*2, CYP2C19*1/*1 and CYP2C19*2/*2. The
total occurrence of clopidogrel low response is 39.5%(79 patients).
There is signiﬁcant difference between clopidogrel low response and
CYP2C19 genotyes, metabolizers, indicating that less patients with
extensive metabolizer (CYP2C19*1/*1) in the clopidogrel response
group, more patients with intermediate or poor metabolizers in the
clopidogrel low response group.
CONCLUSIONS There is correlation between clopidogrel low response
and CYP2C19 gene polymorphism in patients with CAD, more carriers
with intermediate or poor metabolizers in the clopidogrel low
response group.
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Non-alcoholic fatty liver disease affects the relationship between
epicardium and coronary atherosclerotic heart disease
He Cai, Shouyan Hao, Yang Zheng
The ﬁrst hospital of JILIN university
OBJECTIVES To explore the relationship between the various parts of
the visceral fat (VF) and coronary atherosclerotic heart disease (CAD),
and to ﬁnd whether Non-alcoholic fatty liver disease (NAFLD) affects
the correlation between VF and CAD. The results can provide a new
reference index for the prevention, prediction, treatment and reha-
bilitation of CAD.
METHODS This study selected 339 patients, We used ultrasonography
to measure the thickness of various parts VF and NAFLD. According to
the results of coronary angiography, we determined the patients with
CAD and used Gensini value to evaluate the extent of lesion. Firstly,
according to the results of coronary angiography, the patients were
divided into CAD group and non CAD group to determine whether the
VF, NAFLD are the independent risk factors for CAD. Secondly, ac-
cording to Gensini value, the patients were divided into three groups
to investigate whether there is a relationship between VF and the
severity of CAD. Finally, the CAD patients were divided into NAFLD
group and non NAFDL group to determine the relationship between
NAFLD and VF, and the inﬂuence of NAFLD on the relationship be-
tween VF and CAD.
RESULTS Using the single factor analysis, we found that epicardium,
NAFLD, smoking, high blood pressure, HDL-C, LDL-C, TG in CAD
group were signiﬁcantly higher than those in non-CAD group
(P<0.05). There was no signiﬁcant difference between the two groups
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Logistic regression analysis revealed that smoking history, hyperten-
sion, epicardium existed signiﬁcant difference between the CAD
group and the non-CAD group (P<0.05). The thickness of the epicar-
dium and the sum of VF were increased gradually in the three groups
of CAD, and there were signiﬁcant differences between the three
groups (P<0.05). Compared with the non NAFLD group, the thickness
of liver fat, perirenal fat, pararenal fat and epicardium in NAFLD
group were signiﬁcantly increased (P<0.05). In the NAFLD group and
non NAFLD group, the thickness of the epicardium was associated
with CAD, suggesting predictive value for the diagnosis of CAD.
However, the cut-off value of CAD in NAFLD group was higher than
that of non NAFLD group. With the increase of Gensini value, the VF
of NAFLD group had no signiﬁcant increase (P>0.05). With the in-
crease of Gensini value, the epicardium thickness in the three groups
of CAD had a signiﬁcant increase (P<0.05), and the thickness of other
parts VF had no signiﬁcant change (P>0.05).
CONCLUSIONS Epicardium, hypertension, smoking are independent
risk factors for CAD. Epicardium thickness is associated with the de-
gree of coronary artery stenosis. The VF is easily accumulated in the
patients with NAFLD. The epicardium thickness has a predictive value
for the incidence and the severity of CAD in patients without NAFLD.
In patients with NAFLD, epicardium thickness has predictive value for
the incidence of CAD, but there is no predictive value for the severity
of CAD.GW26-e4800
Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels
in coronary artery disease patients with different nutritional status
Sha Li, Ruixia Xu, Yan Zhang, Yuanlin Guo, Chenggang Zhu, Geng Liu,
Qian Dong, Jianjun Li
FuWai Hospital
OBJECTIVES To investigate the association of resistin with propro-
tein convertase subtilisin-kexin type 9 (PCSK9) levels, another novel
regulator of atherosclerosis, in the condition of coronary artery dis-
ease (CAD).
METHODS We prospectively enrolled a total of 356 consecutive stable
CAD patients who were not treated with lipid-lowering drugs in the
present study. The baseline clinical characteristics were collected.
Plasma PCSK9 and resistin levels were determined by ELISA. The
relationship between plasma PCSK9 and resistin levels was
investigated.
RESULTS Overall, plasma resistin exhibited a positive nonparametric
correlation with PCSK9 levels (r¼0.123, p¼0.02). When the patients
were classiﬁed into groups based on body mass index (BMI), the
resistin correlated signiﬁcantly to the PCSK9 levels in patients with
BMI < 25 kg/m2 (r¼0.162, p¼0.026) but not in patients with BMI  25
kg/m2 (r¼0.087, p¼0.205). Multivariate regression analysis corrobo-
rated the relation between the PCSK9 and an elevated resistin level in
patients with BMI < 25 kg/m2 independently of traditional parameters
including age, sex, BMI, smoking, family history of CAD, systolic
blood pressure, glucose, low density lipoprotein cholesterol, white
blood cell, neutrophil to lymphocyte ratio, and high-sensitive C-
reactive protein.
CONCLUSIONS Plasma resistin was positively related to PCSK9 levels
in CAD patients with normal weight, suggesting that the circulating
resistin might represent a link with PCSK9 level variations in CAD
progression of normal body weight.GW26-e5470
The role of circulating miRNAs in diagnosis of acute myocardial infarction
and the pathological signiﬁcance
Ali Sheikh Md Sayed,1 Ping Zhu,2 Li Chuanchang,1 Ke Xia,1,3 Fei Li,1
Xu Deng,1 Umme Salma,4 TianLun Yang,1 Jun Peng5
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of Pharmacology, School of Pharmaceutical Sciences, Central South
University, Changsha ChinaOBJECTIVES We aimed to explore the diagnostic value of circulating
miRNAs (miR-149, miR-208b, miR-378, miR-424, miR-499 and
miR-765) in AMI patients, and protective role of miR-208b or miR-378
or metoprolol during H/R injury in H9c2 cell with their underlying
mechanisms.
METHODS 205 AMI patients and 85 healthy subjects, twelve week-old
C57BL/6 mice AMI and H9c2 cells were included in this study. AMI
patients were diagnosed according to ESC/ACCF/AHA/WHF guide-
lines. Total RNA was isolated from plasma and cardiac cell with TRIzol
reagent. Circulating miRNAs levels were measured by quantitative
real-time polymerase chain reaction.
RESULTS We found that miR-208b, miR-499 and miR-765 levels
were signiﬁcantly up-regulated by 9.6 fold, 5.2 fold, and 5.1 fold
in AMI patients compared with healthy subjects (p<0.001). Plasma
miR-149, miR-378 and miR-424 levels were markedly down-
regulated by 5.5 fold, 4.9 fold and 5 fold in AMI patients compared
with controls (p<0.001). Plasma levels of these miRNAs were
returned towards normal at 96h after PCI (p<0.001). We also found
that plasma miR-208b, miR-499 and miR-765 levels were signiﬁ-
cantly elevated by 11.5 fold, 3.9 fold, and 4.7 fold, while miR-149,
miR-378 and miR-424 levels were noticeably decreased by 3.7 fold,
4.1 fold and 3.8 fold in Mice AMI compared with controls
(p<0.001). The ROC curves of plasma miR-208b, miR-499, miR-765,
miR-149, miR-378 and miR-424 represented a strong discrimina-
tion between AMI patients and healthy subjects, with an area
under curve (AUC) of 0.974, 0.971, 0.965, 0.963 0.969 and 0.973,
respectively.
Moreover, the expression of miR-208b was signiﬁcantly up-regu-
lated in hypoxic/reoxygenation (H/R) injury by 33.36 fold, whereas,
miR-378 was extensively down-regulated in H/R injury by 5.08 fold
compared with controls(p<0.01). Furthermore, inhibition of miR-208b
and over expression of miR-378 were dramatically decreased cell
injury and utmost increased cell survival through negative regulation
of NLK and TRAF6 in H/R injured cardiac cell. Moreover, H/R-induced
H9c2 cells treatment with metoprolol at 106 mM obviously decreased
cell apoptosis, caspase-3 activity, NADPH oxidase activity, LDH
release, and intracellular ROS production, and signiﬁcantly elevated
cell viability (p<0.001).
CONCLUSIONS Our ﬁndings suggested that miR-208b, miR-499,
miR-765, miR-149, miR-378, miR-424 may be used as a novel
and sensitive diagnostic biomarker for AMI patients. Inhibition of
miR-208b and overexpression of miR-378 were effectively protected
cardiomyocyte damage during H/R injury through their potential
targets NLK and TRAF6, represents a new therapeutic approach for
ischemic heart disease. Furthermore, metoprolol protected car-
diomyocytes damage against H/R injury by suppressing oxidative
stress.
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Health - related Quality of Life of Patients with Coronary Heart Disease
Attending in a Cardiac Care Centre, Kathmandu
Rosy Shrestha
Institute of Medicine, Nursing Campus Maharajganj
OBJECTIVES Coronary heart disease (CHD) is a leading cause of
morbidity and mortality in adults worldwide. It is gradually emerging
as a major public health problem in many developing countries
including Nepal. Consequences of CHD are that it often results in
depletion of the health related quality of life (HRQL) of patients. The
aim of this study was to assess the HRQL of CHD patients.
METHODS A descriptive cross sectional design was used to assess
HRQL of 254 CHD patients attending out-patient department of Sha-
hid Gangalal National Heart Centre (SGNHC), Bansbari, Kathmandu,
Nepal. Purposive sampling technique was used for data collection by
face to face interview technique using the MacNew Health - related
Quality of Life tool.
RESULTS The results of the study showed that mean  SD for
emotional domain was 3.87  1.01, for physical domain was 3.81 
0.88 and social domain was 3.82  0.88 and global score of HRQL was
3.83  0.87 on 7- point likert scale. As the different domains of HRQL
was signiﬁcantly correlated with each others. The descriptive statis-
tics of individual domain scores according to level of HRQL was found
to be greater number in below average group in each domain
including global HRQL score.
CONCLUSIONS The HRQL score of CHD patients attending a cardiac
centre are below average. Hence, Self Instructional Module (SIM) on
“Living well with CHD” should be developed to enhanced quality
of life.
